| scholarly article | Q13442814 |
| P2093 | author name string | Paul J Lombroso | |
| Susan M Goebel-Goody | |||
| P2860 | cites work | Correction of fragile X syndrome in mice. | Q22251255 |
| Altered synaptic plasticity in a mouse model of fragile X mental retardation | Q24530695 | ||
| Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum | Q24563279 | ||
| Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src) | Q24618435 | ||
| Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61 | Q24620404 | ||
| Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease | Q24620534 | ||
| ARF6 stimulates clathrin/AP-2 recruitment to synaptic membranes by activating phosphatidylinositol phosphate kinase type Igamma | Q24675779 | ||
| Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking | Q24681745 | ||
| Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model | Q26781974 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses | Q28208647 | ||
| Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression | Q28257629 | ||
| A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures | Q28260578 | ||
| STEP61: a member of a family of brain-enriched PTPs is localized to the endoplasmic reticulum | Q28300811 | ||
| Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome | Q28302665 | ||
| Regulation of NMDA receptor trafficking by amyloid-beta | Q28506085 | ||
| NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling | Q28567230 | ||
| Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP | Q28567752 | ||
| Characterization of the role of microtubule-associated protein 1B in metabotropic glutamate receptor-mediated endocytosis of AMPA receptors in hippocampus | Q28569108 | ||
| A substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatum | Q28573319 | ||
| Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase | Q28574038 | ||
| NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity | Q28584848 | ||
| Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD | Q28585633 | ||
| The fragile X mental retardation protein inhibits translation via interacting with mRNA | Q28588486 | ||
| Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors | Q28771397 | ||
| The mGluR theory of fragile X mental retardation | Q29615060 | ||
| Seizure susceptibility and mortality in mice that over-express amyloid precursor protein | Q30482779 | ||
| The striatal-enriched protein tyrosine phosphatase gates long-term potentiation and fear memory in the lateral amygdala | Q30498983 | ||
| Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor | Q31451987 | ||
| FMRP mediates mGluR5-dependent translation of amyloid precursor protein | Q33273636 | ||
| Synaptic targeting by Alzheimer's-related amyloid beta oligomers. | Q33288786 | ||
| Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation | Q33288870 | ||
| The structural era of endocytosis | Q33683033 | ||
| Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum | Q33723743 | ||
| Advances in understanding the molecular basis of FXTAS | Q33871325 | ||
| Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome | Q33953276 | ||
| The ubiquitin-proteasome pathway and synaptic plasticity | Q33994715 | ||
| Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. | Q34126102 | ||
| Identification of two alternatively spliced transcripts of STEP: a subfamily of brain-enriched protein tyrosine phosphatases | Q34289947 | ||
| STEP regulation of seizure thresholds in the hippocampus. | Q34680506 | ||
| Mitogen-activated protein kinases in synaptic plasticity and memory. | Q35803116 | ||
| Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome | Q36670213 | ||
| The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. | Q36980688 | ||
| Knockout of striatal enriched protein tyrosine phosphatase in mice results in increased ERK1/2 phosphorylation | Q37252338 | ||
| Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. | Q37387675 | ||
| MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta | Q37418819 | ||
| Cell migration in the normal and pathological postnatal mammalian brain | Q37476131 | ||
| The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. | Q37589711 | ||
| Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission | Q37632803 | ||
| AMPA receptor signaling through BRAG2 and Arf6 critical for long-term synaptic depression | Q39693283 | ||
| Amyloid peptide attenuates the proteasome activity in neuronal cells | Q40375322 | ||
| Transient compartmental expression of a family of protein tyrosine phosphatases in the developing striatum | Q40949559 | ||
| Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors | Q41825065 | ||
| Tyrosine dephosphorylation regulates AMPAR internalisation in mGluR-LTD. | Q42446128 | ||
| Immunocytochemical localization of the striatal enriched protein tyrosine phosphatase in the rat striatum: a light and electron microscopic study with a complementary DNA-generated polyclonal antibody | Q42515643 | ||
| Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome | Q42530481 | ||
| Molecular determinants of NMDA receptor internalization | Q43690729 | ||
| Internalization of ionotropic glutamate receptors in response to mGluR activation | Q43785653 | ||
| Protein composition of the intranuclear inclusions of FXTAS. | Q44053371 | ||
| Dynamics and regulation of clathrin coats at specialized endocytic zones of dendrites and spines | Q44199588 | ||
| Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases. | Q44969005 | ||
| Glutamate receptor-interacting protein 1 protein binds to the microtubule-associated protein | Q45025438 | ||
| Stimulated regeneration of the crushed adult rat optic nerve correlates with attenuated expression of the protein tyrosine phosphatases RPTPalpha, STEP, and LAR. | Q45157608 | ||
| NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout mice | Q45349101 | ||
| Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). | Q46007399 | ||
| Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers | Q46124789 | ||
| Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices | Q46223156 | ||
| Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain | Q46386576 | ||
| Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. | Q46463850 | ||
| Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. | Q46626541 | ||
| Tyrosine phosphatases regulate AMPA receptor trafficking during metabotropic glutamate receptor-mediated long-term depression. | Q46970980 | ||
| Hypoxia-ischemia in perinatal rat brain induces the formation of a low molecular weight isoform of striatal enriched tyrosine phosphatase (STEP). | Q47254738 | ||
| STEP: a family of brain-enriched PTPs. Alternative splicing produces transmembrane, cytosolic and truncated isoforms | Q48051830 | ||
| Early postnatal plasticity in neocortex of Fmr1 knockout mice | Q48478142 | ||
| Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. | Q48577748 | ||
| Postnatal ontogeny of striatal-enriched protein tyrosine phosphatase (STEP) in rat striatum | Q48713814 | ||
| Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. | Q51074301 | ||
| Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome. | Q51891210 | ||
| Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. | Q51978092 | ||
| Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP). | Q52013286 | ||
| Lateral organization of endocytic machinery in dendritic spines. | Q52087997 | ||
| Calcium-dependent cleavage of striatal enriched tyrosine phosphatase (STEP) | Q73120747 | ||
| Impaired proteasome function in Alzheimer's disease | Q73897101 | ||
| P921 | main subject | fragile X syndrome | Q221472 |
| P304 | page(s) | 223-241 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Results and problems in cell differentiation | Q26842363 |
| P1476 | title | Taking STEPs forward to understand fragile X syndrome | |
| P478 | volume | 54 |
| Q45957740 | Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. |
| Q36925690 | Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue |
| Q34435526 | Increasing our understanding of human cognition through the study of Fragile X Syndrome |
| Q39120013 | Lens Biology is a Dimension of Neurobiology |
| Q91613577 | Molecular Biomarkers in Fragile X Syndrome |
| Q36081738 | Regulation of STEP61 and tyrosine-phosphorylation of NMDA and AMPA receptors during homeostatic synaptic plasticity |
| Q27023257 | Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes |
| Q26828004 | The function of metabotropic glutamate receptors in thalamus and cortex |
Search more.